Skip to main content
Donate

Up Next

McMaster: U.S. has 'partnered' with Taliban in Afghanistan

McMaster: U.S. has 'partnered' with Taliban in Afghanistan

Video
7:12
Coons: Trump’s defiance ‘putting American lives at risk'

Coons: Trump’s defiance ‘putting American lives at risk'

Video
6:46
Can the Boy Scouts survive a flood of sexual abuse claims?

Can the Boy Scouts survive a flood of sexual abuse claims?

Video
5:52
These Parkinson's patients find relief at the barre

These Parkinson's patients find relief at the barre

Video
5:04
Christopher Krebs defended the election. Trump fired him

Christopher Krebs defended the election. Trump fired him

Video
4:46
A year after COVID appeared, Wuhan tells China's virus story

A year after COVID appeared, Wuhan tells China's virus story

Video
6:33
Social media CEOs defend content policies to Senate panel

Social media CEOs defend content policies to Senate panel

Video
4:12
News Wrap: U.S. COVID cases rise 80 percent in 2 weeks

News Wrap: U.S. COVID cases rise 80 percent in 2 weeks

Video
4:39
Why election officials say this vote was 'the most secure'

Why election officials say this vote was 'the most secure'

Video
6:45
How GOP is reacting to Trump's continued election defiance

How GOP is reacting to Trump's continued election defiance

Video
5:05
News Wrap: U.S. imposes new sanctions on Iran

News Wrap: U.S. imposes new sanctions on Iran

Video
4:55
How Trump could complicate federal government funding

How Trump could complicate federal government funding

Video
5:34
Back to Show
PBS News Hour

What we know about Moderna's COVID-19 vaccine candidate

The drug company Moderna has released encouraging data from research on its COVID-19 vaccine candidate. The research has not yet been published in a peer-reviewed medical journal, but it is nonetheless raising hopes. Noubar Afeyan is a co-founder and chairman of Moderna and the CEO of Flagship Pioneering, a venture capital firm that helped launch Moderna. He joins Judy Woodruff to discuss.